NSE · WINDLAS
Windlas Biotech Limited
₹949.45
-0.01%
Market Cap
2,003.91 Cr
P/E Ratio
30.05
P/B Ratio
3.45
ROE
11.44%
ROCE
15.65%
Dividend Yield
0.66%
52W High
₹1,097.90
52W Low
₹731.75
Quarterly financials
| Metric | Q1 2026-27 | Q4 2025-26 |
|---|---|---|
| Revenue | 248.10 Cr | 238.50 Cr |
| Net Profit | 17.65 Cr | 15.99 Cr |
| EPS | 8.46 | 7.58 |
| Operating Profit | 24.59 Cr | 21.64 Cr |
Shareholding pattern
Promoter
63.31%
Public
36.69%
FII
—
DII
—
Recent corporate actions
| Ex-Date | Type | Details |
|---|---|---|
| 16 Jul 2026 | Dividend | Dividend - Rs 6.30 Per Share |
| 24 Apr 2026 | Buyback | Buy Back |
| 21 Jul 2025 | Dividend | Dividend - Rs 5.80 Per Share |
| 17 Sep 2024 | Other | Annual General Meeting |
| 17 Sep 2024 | Dividend | Dividend - Rs 5.50 Per Share |
Need this data in your app?
Full price history, technical indicators, and every field above via one REST API call.